Product category:
Clinical chemistry analysis
News Release from: Perkin Elmer LAS (UK) | Subject: NeoGram
Edited by the Laboratorytalk Editorial
Team on 12 November 2004
Expanded newborn screening in California
Tandem mass spectrometry system and reagent kits screen for over 40 disease markers will be supplied for state-wide expansion of newborn screening programme
PerkinElmer has signed long-term agreements with the state of California to supply tandem mass spectrometry systems in support of the state's expanded newborn screening programme PerkinElmer's NeoGram amino acids and acylcarnitines kit recently became the world's first multi-analyte kit cleared by the FDA for newborn metabolic screening using tandem mass spectrometry
This article was originally published on Laboratorytalk on 18 Nov 2002 at 8.00am (UK)
Related stories
Breakthrough newborn screening system
Phenylalanine test system, consisting of a reagent kit, software, and tandem mass spectrometer, will be used worldwide in the identification of phenylketonuria in newborns
Clearance for newborn screening system
Tandem mass spectrometry kit screens for metabolic disorders, analysing more than 40 disease markers with a single blood sample to enable early detection and intervention
Subsequent to validation of requested enhancements, PerkinElmer will provide California's contracted newborn screening laboratories with tandem mass spectrometry systems, reagent kits, and software.
In addition, a system will be placed in California's Genetic Disease Laboratory (GDL) located in Richmond, California, where trained scientists will oversee and analyse all of the results from the screening labs, and perform quality control oversight.
PerkinElmer will also provide California's contracted newborn screening laboratories with 17-OHP assay kits, which allows for the screening of congenital adrenal hyperplasia (CAH).
CAH can be fatal if left undetected.
PerkinElmer anticipates that this system will be available for sale in late 2004 or early 2005.
"We are pleased to continue to support the state of California in its effort to develop a state-of-the-art newborn screening program," said Gregory Summe, PerkinElmer chairman and chief executive officer.
"By utilising PerkinElmer's leading-edge technology, an early detection programme allows for treatment and management options for a range of diseases, leading to an improved quality of life".
PerkinElmer claims to be is the world's leading supplier to newborn screening laboratories, saying that every baby screened in the USA today is tested with one of its products.
• Perkin Elmer LAS (UK): contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
